Rice Hall James & Associates LLC bought a new position in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 166,047 shares of the company's stock, valued at approximately $1,795,000. Rice Hall James & Associates LLC owned about 0.10% of Integral Ad Science as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently made changes to their positions in IAS. Jupiter Asset Management Ltd. bought a new stake in Integral Ad Science in the first quarter valued at $3,257,000. Vanguard Group Inc. boosted its holdings in shares of Integral Ad Science by 10.7% during the 4th quarter. Vanguard Group Inc. now owns 8,106,247 shares of the company's stock valued at $116,649,000 after buying an additional 780,469 shares in the last quarter. Clearline Capital LP bought a new stake in shares of Integral Ad Science during the 2nd quarter valued at $916,000. TimesSquare Capital Management LLC boosted its holdings in shares of Integral Ad Science by 9.9% during the 1st quarter. TimesSquare Capital Management LLC now owns 2,969,278 shares of the company's stock valued at $29,604,000 after buying an additional 268,310 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. boosted its holdings in shares of Integral Ad Science by 4.7% during the 1st quarter. Jacobs Levy Equity Management Inc. now owns 1,246,556 shares of the company's stock valued at $12,428,000 after buying an additional 55,844 shares in the last quarter. Institutional investors own 95.78% of the company's stock.

Shares of NASDAQ:IAS opened at $11.90 on Friday. Integral Ad Science Holding Corp. has a fifty-two week low of $7.98 and a fifty-two week high of $17.53. The business has a 50-day simple moving average of $11.02 and a two-hundred day simple moving average of $10.30. The company has a debt-to-equity ratio of 0.10, a quick ratio of 3.76 and a current ratio of 3.76. The firm has a market cap of $1.92 billion, a price-to-earnings ratio of 1,191.19, a price-to-earnings-growth ratio of 1.41 and a beta of 1.54.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its quarterly earnings data on Thursday, August 1st. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.03. Integral Ad Science had a net margin of 0.57% and a return on equity of 0.31%. The firm had revenue of $129.01 million for the quarter, compared to analysts' expectations of $126.31 million. During the same quarter in the prior year, the business earned $0.05 EPS. The business's quarterly revenue was up 13.5% on a year-over-year basis. On average, analysts expect that Integral Ad Science Holding Corp. will post 0.29 earnings per share for the current year.

In related news, CEO Lisa Utzschneider sold 10,481 shares of the stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $105,962.91. Following the completion of the sale, the chief executive officer now directly owns 239,709 shares of the company's stock, valued at approximately $2,423,457.99. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, CEO Lisa Utzschneider sold 10,481 shares of the stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $105,962.91. Following the completion of the sale, the chief executive officer now directly owns 239,709 shares of the company's stock, valued at approximately $2,423,457.99. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Tania Secor sold 6,643 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $11.24, for a total transaction of $74,667.32. Following the completion of the sale, the chief financial officer now directly owns 251,366 shares of the company's stock, valued at $2,825,353.84. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 32,357 shares of company stock valued at $342,409. 2.00% of the stock is owned by corporate insiders.

A number of analysts have recently commented on the stock. Barclays boosted their target price on shares of Integral Ad Science from $12.00 to $13.00 and gave the company an "equal weight" rating in a report on Monday, August 5th. Benchmark restated a "hold" rating on shares of Integral Ad Science in a report on Monday, August 5th. Morgan Stanley boosted their target price on shares of Integral Ad Science from $12.00 to $13.00 and gave the company an "equal weight" rating in a report on Tuesday, July 23rd. Finally, Raymond James lifted their price target on Integral Ad Science from $13.00 to $15.00 and gave the stock an "outperform" rating in a research report on Friday, August 2nd. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $16.40.

Check Out Our Latest Stock Analysis on Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider Integral Ad Science, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.

While Integral Ad Science currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.